Global Molecular Diagnostics Market: Snapshot
Molecular diagnostics is an integral part of the in vitro diagnostics industry and has gained an accelerated momentum in recent years. The introduction of tests for Chlamydia trachomatis and Neisseria gonorrhea (CT/NG) and HIV have augmented the demand for PCR technology have completely transformed the earnings of this market over the past two decades. Presently, molecular diagnositcs are extensively used for diagnosing and predicting various genetic disease, hepatitis virus, cancer, and hospital-acquired infections. Furthermore, these kits are also being used for blood donor screening test for HIV and hepatitis. Owing to these reasons, the global molecular diagnostics market is expected to progress at a CAGR of 11.6% between 2016 and 2025. The report states that the global market is expected to be worth US$18.9 bn by the end of 2025 as compared to US$7.1 bn in 2016.
The research report states that the global molecular diagnostics market is likely to rise against the backdrop of rising pool of the geriatric population, growing demand for personalized health care, and increasing awareness about molecular diagnostics. The market is also expected to grow due to the continuous development in the field of molecular biology. Furthermore, the market is expected to benefit from the increasing investments in research and development of improved molecular diagnostic kits that deliver accurate results.
Cost-effective Amplification Offered by Polymerase Chain Reaction Boosts Segment
On the basis of technology, the global molecular diagnostic tests market is segmented into polymerase chain reaction, and Real-Time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others (mass spectrometry etc.). Out of these, the polymerase chain reaction held the largest share in the overall market, accounting for the share of 39.1%in 2016. The robust demand for this technology is attributable to its cost-effectiveness in copying or amplification of small segments of DNA or RNA. During the forecast period, the next generation sequencing segment is anticipated to showcase a rapid growth rate due to its phenomenal throughput, improved speed, and enhanced flexibility, which delivers hundreds of gigabases of data in a single sequencing run. Techniques such as hybridization, microarray, and transcription-mediated amplification are also expected to shine during the forecast period.
North America Leads Global Market as Consumers Prefer Affordable Testing
On the basis of geography, the global molecular diagnostics market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2016, North America held a leading share of 39.1% in the global market. This dominance was due to high prevalence of infectious diseases and rising number of initiatives by governments to raise awareness. Furthermore, the emerging trend of patients opting for molecular diagnostic tests as they are affordable is also contributing to the growth of this regional market. Analysts anticipate that Asia Pacific is also expected to offer several lucrative opportunities to the global market during the forecast period. The demand for molecular diagnostics in Asia Pacific is expected to be propelled by the rising disposable income among the population, growing concerns about health, and improving awareness about molecular diagnostic tests.
The key players operating in the global molecular diagnostic market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG, and Thermo Fisher Scientific Inc. As of 2016, F. Hoffmann-La Roche Ltd dominated the global competitive landscape due to its wide product portfolio and its sprawling presence. The report suggests that Abbott Laboratories followed this lead to be in the second place, while Danaher Corporation ranked number three in the global market.
Global Molecular Diagnostics Market: Overview
This report on the molecular diagnostics market studies the current and future prospects of the market globally. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia hepatitis, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of global molecular diagnostics market. The global molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global molecular diagnostics market with respect to market segments based on technology, application, end user and their geographic analysis.
Global Molecular Diagnostics Market: Segmentation
Based on technology, the molecular diagnostics market has been segmented into six major categories: PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing and others which includes mass spectrometry etc. These are the major techniques which are used in molecular diagnostics for diagnosis of disease. Likewise, on the basis of application, the global molecular diagnostics market has been segmented into infectious diseases, oncology, blood screening, microbiology, genetic testing and women’s health. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2015 to 2025. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2015 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the global molecular diagnostics report.
Based on End User the global molecular diagnostics market is segmented as hospitals, diagnostic laboratories, blood banks, academics & research and others. The market size and forecast for each of these end user has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year.
Global Molecular Diagnostics Market: Regional Outlook
Geographically, the molecular diagnostics market in Europe has been categorized into five major regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2015 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving that is supply side driver, demand side driver and economic driver, restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share analysis by key players, competitive matrix thus presenting a thorough analysis of the overall competitive scenario in the global molecular diagnostics market.
Key Players Mentioned in this Report are:
Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the global molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments, SWOT analysis. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V. ,bioMérieux SA, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG and Thermo Fisher Scientific Inc., and others.
The global molecular diagnostics market is segmented as given below:
Global Molecular Diagnostics Market, by Technology
- PCR and Real-Time PCR
- Hybridization
- Microarray
- Transcription-Mediated Amplification
- Next-Generation Sequencing
- Others (Mass Spectrometry, etc.)
Global Molecular Diagnostics Market, by Application
- Infectious Diseases
- Oncology
- Blood Screening
- Microbiology
- Genetic Testing
- Women’s Health
Global Molecular Diagnostics Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Academics
- Research
Global Molecular Diagnostics Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- Australia
- India
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
